Finance

Lists
Why is OKUR up 4,78%?
Dive Deeper
OKUR:NASDAQ
Onkure Therapeutics Inc
2,41 US$
+4,78%
(+0,11) 1D
2,43 US$
+0,83% (+0,020)
Pre-market
Closed: 9 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OKUR...
Open
2,29 US$
High
2,42 US$
Low
2,23 US$
Mkt. cap
97,60 მლნ.
Avg. vol.
311,73 ათ.
Volume
0,00
52-wk high
5,38 US$
52-wk low
2,13 US$
EPS
-3,50 US$
Beta
0,12
Shares outstanding
40,50 მლნ.
No. of employees
45
Open
2,29 US$
High
2,42 US$
Low
2,23 US$
Mkt. cap
97,60 მლნ.
Avg. vol.
311,73 ათ.
Volume
0,00
52-wk high
5,38 US$
52-wk low
2,13 US$
EPS
-3,50 US$
Beta
0,12
Shares outstanding
40,50 მლნ.
No. of employees
45
News stories
From web sources and news partners
About Onkure Therapeutics Inc
CEO-
Employees45
Founded2011
Headquartersბაულდერი, კოლორადოს შტატი, ამერიკის შეერთებული შტატები
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to OKUR in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for OKUR in the last 3 months.
Highest
Current 2,41 US$
21,00 US$ (+771,37%)
Average
17,00 US$ (+605,39%)
Lowest
14,00 US$ (+480,91%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Biegler
Oppenheimer
Buy
Reiterated
14,00 US$
+480,9%
08/14/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
14,00 US$
+480,9%
08/14/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
16,00 US$
+563,9%
08/05/2026
Boris Peaker
JonesTrading
Hold
Maintained
-
-
08/05/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
21,00 US$
+771,4%
07/20/2026
Soumit Roy
JonesTrading
Buy
Maintained
17,00 US$
+605,4%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11,92 მლნ.
10,72 მლნ.
11,71 მლნ.
12,61 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,59 მლნ.
3,40 მლნ.
3,91 მლნ.
4,29 მლნ.
Operating expense
15,50 მლნ.
14,12 მლნ.
15,62 მლნ.
16,90 მლნ.
Total operating expenses
15,50 მლნ.
14,12 მლნ.
15,62 მლნ.
16,90 მლნ.
Operating income
-15,50 მლნ.
-14,12 მლნ.
-15,62 მლნ.
-16,90 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
-14,70 მლნ.
-13,50 მლნ.
-15,16 მლნ.
-15,35 მლნ.
EBT excluding unusual items
-14,70 მლნ.
-13,50 მლნ.
-15,16 მლნ.
-15,35 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14,70 მლნ.
-13,50 მლნ.
-15,16 მლნ.
-15,35 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-1,09
-0,99
-1,11
-0,31
Interest and investment income
804,00 ათ.
628,00 ათ.
458,00 ათ.
1,55 მლნ.
Interest expense
-2,00 ათ.
-6,00 ათ.
-
-
Net interest expenses
802,00 ათ.
622,00 ათ.
458,00 ათ.
1,55 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-15,39 მლნ.
-14,02 მლნ.
-15,51 მლნ.
-16,81 მლნ.
Gain or loss from assets sale
2,00 ათ.
4,00 ათ.
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები